Research output
- 12 Article
-
Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
Stegemann, M., Macherndl-Spandl, S., Mairhofer, M., Kaltenbrunner, S., Buxhofer-Ausch, V., Clausen, J., Petzer, A. & Schmitt, C. A., Apr 2026, In: Leukemia and Lymphoma. 67, 5, p. 1147-1151 5 p.Research output: Contribution to journal › Article › peer-review
-
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19
Lee, S., Yu, Y., Trimpert, J., Benthani, F., Mairhofer, M., Richter-Pechanska, P., Wyler, E., Belenki, D., Kaltenbrunner, S., Pammer, M., Kausche, L., Firsching, T. C., Dietert, K., Schotsaert, M., Martínez-Romero, C., Singh, G., Kunz, S., Niemeyer, D., Ghanem, R. & Salzer, H. J. F. & 28 others, , Feb 2025, In: Nature. 638, 8052, p. E46 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Pammer, M., Ghanem, R., Stegemann, M. & Schmitt, C. A., 21 Nov 2025, In: iScience. 28, 11, 113727.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients (iScience (2025) 28(11), (S2589004225019881), (10.1016/j.isci.2025.113727))
Mairhofer, M., Kausche, L., Kaltenbrunner, S., Pammer, M., Ghanem, R., Stegemann, M. & Schmitt, C. A., 21 Nov 2025, In: iScience. 28, 11, 113890.Research output: Contribution to journal › Article › peer-review
Open Access -
Bi-allelic mutation in SEC16B alters collagen trafficking and increases ER stress
El-Gazzar, A., Voraberger, B., Rauch, F., Mairhofer, M., Schmidt, K., Guillemyn, B., Mitulović, G., Reiterer, V., Haun, M., Mayr, M. M., Mayr, J. A., Kimeswenger, S., Drews, O., Saraff, V., Shaw, N., Fratzl-Zelman, N., Symoens, S., Farhan, H. & Högler, W., 11 Apr 2023, In: EMBO Molecular Medicine. 15, 4, 20 p., e16834.Research output: Contribution to journal › Article › peer-review
Open Access
-
Cellular and Humoral Immune Responses in SARS-CoV-2 Triple-Vaccinated Cancer Patients
Mairhofer, M. (Speaker)
13 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Cellular and Humoral Immune Responses in SARS-CoV-2 Triple-Vaccinated Cancer Patients
Mairhofer, M. (Speaker)
13 Nov 2025Activity: Talk or presentation › Invited talk › science-to-science
-
Peptide- and state-specific T-cell activities
Mairhofer, M. (Speaker)
30 Aug 2022Activity: Talk or presentation › Contributed talk › science-to-science
-
Befehl zum Sterben: Wie beeinflusst vorzeitige Zellalterung Krebstherapien?
Mairhofer, M. (Speaker), Benthani, F. (Speaker) & Kaltenbrunner, S. (Speaker)
20 May 2022Activity: Talk or presentation › Contributed talk › science-to-public